Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI.

Stanley CE, Fabrizio K, McMahon BA, Matthews-McGee A, Fitzgerald C, Singh Z, Rigby NH, Talarico JM, Brown EG, Korell M, McGuire Kuhl M, Destro C, Pavese N, Garrido A, Mollenhauer B, Chowdhury S, Marek K, Tanner CM, Tropea TF, Parkinson's Progression Markers Initiative.

Ann Neurol · 2026-04-21

DOI: 10.1002/ana.78230PMID: 42015362

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Clinical Progression in Alpha-Synuclein Positive LRRK2-PD and Sporadic Parkinson's Disease: A Longitudinal Analysis.

Morse LA, Choi SH, Gochanour C, Lafontant DE, Chahine LM, Merchant KM, Wendelberger B, Simuni T, Parkinson's Progression Markers Initiative.

Mov Disord Clin Pract · 2026-04-19

DOI: 10.1002/mdc3.70640PMID: 42003081

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Wearable-sensor based walking and non-walking measures as progression markers in early to mid-stage Parkinson's disease.

Ho KC, Li S, Serrano-Amenos C, Kowahl N, Rainaldi E, Chen C, Bloem BR, Sanders LH, Shih LC, Siderowf A, Marks WJ, Kapur R, Evers LJW, Shin S.

NPJ Parkinsons Dis · 2026-04-18

DOI: 10.1038/s41531-026-01358-zPMID: 42000835

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Tracking ClO<sup>-</sup> Dynamics during the Progression of Parkinson's Disease in MPTP Mouse Model Using <i>In Vivo</i> Brain Microdialysis.

Cheng Y, Jiang C, Zhang Z, Zheng X, Zhang Z, Lu H, Zhang Q.

ACS Chem Neurosci · 2026-04-15

DOI: 10.1021/acschemneuro.5c00886PMID: 41983537

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Retrospective longitudinal analysis of blood microRNA-7-5p as a possible progression biomarker in people with Parkinson's disease.

Zadegan SA, Hutchinson C, Onuigbo C, Martinez-Lemus JD, Talbot L, Metter EJ, Doursout MF, Tharp E, Suescun J, Shahnawaz M, Ellmore TM, Schiess M, Adams C.

Front Neurosci · 2026-04-14

DOI: 10.3389/fnins.2026.1784013PMID: 42057903

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The Syn-Q study: detection of cutaneous phosphorylated alpha-synuclein in Parkinson's disease progression: a trial protocol.

Parent JH, Levine T, Freeman R, Gibbons CH.

Front Neurol · 2026-04-14

DOI: 10.3389/fneur.2026.1823991PMID: 42057930

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Patterns of weariness-related symptoms in Parkinson's disease: impact of disease progression and levodopa treatment.

Hersonsky D, Benesh A, Ben-Ami E, Raveh E.

Clin Park Relat Disord · 2026-04-11

DOI: 10.1016/j.prdoa.2026.100442PMID: 42016530

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Braking Parkinson's progression: the hypothetical druggable role of striatal parvalbumin interneurons.

He Q, Wang X, Zhang X, Shu Y.

NPJ Parkinsons Dis · 2026-04-08

DOI: 10.1038/s41531-026-01303-0PMID: 41951621

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Association of Gastrointestinal Symptoms With Severity and Progression of Cognitive Impairment in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Ho K, Khan J, Cheloff AZ, Malhotra A, Shaukat A.

J Gastroenterol Hepatol · 2026-04-08

DOI: 10.1111/jgh.70373PMID: 41948786

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Predicting Long-Term Depression Progression in Parkinson's Disease: A Machine-Learning Survival Analysis and Risk Score.

Liu D, Qi C, Huang J, Xie H, Zhuang Y, Zhang Q, Zhao X, Hu T, Qin G, Lu Y, Zhang X, Li S, Yang M, Zhang J, Jiang Y.

CNS Neurosci Ther · 2026-04-01

DOI: 10.1002/cns.70845PMID: 41902606

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Peripheral inflammation predicts motor, cognitive, and disease progression in Parkinson's disease: A 4-year longitudinal study from the PPMI cohorts.

Chen Z, Xie L, Jin Q, Shi M.

Neurol Sci · 2026-03-30

DOI: 10.1007/s10072-026-09002-7PMID: 41906023

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Precise disease heterogeneity and progression quantification in MSA and Parkinson's disease using machine learning.

Gebre RK, Raghavan S, De Tora MEJ, Fought AJ, Reid RI, Low PA, Singer W, Vemuri P.

Sci Rep · 2026-03-30

DOI: 10.1038/s41598-026-45949-5PMID: 41912595

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

1.057 makale bulundu

Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI.

Clinical Progression in Alpha-Synuclein Positive LRRK2-PD and Sporadic Parkinson's Disease: A Longitudinal Analysis.

Wearable-sensor based walking and non-walking measures as progression markers in early to mid-stage Parkinson's disease.

Tracking ClO<sup>-</sup> Dynamics during the Progression of Parkinson's Disease in MPTP Mouse Model Using <i>In Vivo</i> Brain Microdialysis.

Retrospective longitudinal analysis of blood microRNA-7-5p as a possible progression biomarker in people with Parkinson's disease.

The Syn-Q study: detection of cutaneous phosphorylated alpha-synuclein in Parkinson's disease progression: a trial protocol.

Patterns of weariness-related symptoms in Parkinson's disease: impact of disease progression and levodopa treatment.

Braking Parkinson's progression: the hypothetical druggable role of striatal parvalbumin interneurons.

Association of Gastrointestinal Symptoms With Severity and Progression of Cognitive Impairment in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Predicting Long-Term Depression Progression in Parkinson's Disease: A Machine-Learning Survival Analysis and Risk Score.

Peripheral inflammation predicts motor, cognitive, and disease progression in Parkinson's disease: A 4-year longitudinal study from the PPMI cohorts.

Precise disease heterogeneity and progression quantification in MSA and Parkinson's disease using machine learning.

Filtreler